Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Beta Drugs Ltd.
NSE: BETA
|
BSE: 531481
|
ISIN: INE351Y01019
|
Industry: Pharmaceuticals
|
Expensive Performer
2218.5000
-40.40
(
-1.79
%)
NSE
Sep 04, 2026
15:31 PM
124.07% Gain from 52W Low
Volume:
13,251
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Beta Drugs Ltd.
16 May 2024
2218.50
-1.79%
Beta Drugs Ltd | H2FY24 Result Update
Buy:
Beta Drugs Ltd.
by
Edelweiss
Target: 1600
Target
Edelweiss
Deepening its roots in the market
Beta Drugs Ltd. is trading
above its 200 day SMA
of 1655.3
More from Beta Drugs Ltd.
Recommended
Five Interesting Stocks Today - September 4, 2026
The Baseline |
04 Sep 2026, 06:53PM
Market closes higher as Fed rate hike concerns ease
Trendlyne Marketwatch |
04 Sep 2026, 03:58PM
India’s gold-loan rush: Bigger books, tighter margins
The Baseline |
03 Sep 2026, 04:34PM